ARTICLE | Product Development

21st century pandemic, prehistoric clinical trials: Guest Commentary

It’s long past time to embrace randomized controlled trials as the fastest path to answers in a pandemic, says Luciana Borio

June 26, 2020 6:26 PM UTC

The U.S. is trying to fight a 21st century pandemic with prehistoric clinical trials -- and achieving the kind of efficiency you might expect.

In the last six months, tens of thousand of patients have been enrolled in thousands of clinical trials all over the world, yet these studies have produced actionable answers on only three agents: remdesivir, dexamethasone and hydroxychloroquine. ...